One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study
Background In non-high-risk individuals, risk-category-based atherosclerotic cardiovascular
disease (ASCVD) screening strategies may be more cost-effective than one-size-fits-all …
disease (ASCVD) screening strategies may be more cost-effective than one-size-fits-all …
[HTML][HTML] Impact of China's low centralized medicine procurement prices on the cost-effectiveness of statins for the primary prevention of atherosclerotic cardiovascular …
M Wang, J Liu, BK Bellows, Y Qi, J Sun, J Liu… - Global Heart, 2020 - ncbi.nlm.nih.gov
Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease
(ASCVD). China's new central government medicine procurement policy lowered statin …
(ASCVD). China's new central government medicine procurement policy lowered statin …
[HTML][HTML] Serum triglyceride level and hypertension are highly associated with the recovery of COVID-19 patients
L Wang, Y Zhang, Y Cheng, C Li, Y Wang… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Abstract The coronavirus disease-19 (COVID-19) has been a global pandemic and caused
thousands of deaths worldwide. So far, although some studies suggested some medications …
thousands of deaths worldwide. So far, although some studies suggested some medications …
Ten-year Time-trend Analysis of Dyslipidemia Among Adults in Wuhan
M Zhang, Z Wan, Y Lv, Y Huang, L Hu, H Xu… - Current Medical …, 2022 - Springer
Objective Dyslipidemia is associated with an increased risk of cardiovascular disease, the
major cause of death in an aging population. This study aimed to estimate the prevalence of …
major cause of death in an aging population. This study aimed to estimate the prevalence of …
Health Economics Assessment of Statin Therapy Initiation Thresholds for Atherosclerosis Prevention in China: a Cost-Effectiveness Analysis
T Feng, X Zhang, J Xu, S Gao, X Yu - medRxiv, 2023 - medrxiv.org
Abstract Background The latest revised Chinese guidelines for the management of
dyslipidemia have lowered the 10-year risk threshold for initiating statins for primary …
dyslipidemia have lowered the 10-year risk threshold for initiating statins for primary …
Burden of cardiovascular diseases associated with fine particulate matter in Beijing, China: an economic modelling study
Objective To evaluate the economic and humanistic burden associated with cardiovascular
diseases that were attributable to fine particulate matter (≤ 2.5 μg/m3 in aerodynamic …
diseases that were attributable to fine particulate matter (≤ 2.5 μg/m3 in aerodynamic …
[PDF][PDF] 基于PEERs的国内他汀类药物经济学研究质量评估*
沈瑛莹， 何晓静， 菅凌燕 - 医药导报, 2021 - yydbzz.com
目的了解国内他汀类药物经济学研究质量, 明确其中需要改善和规范的关键点. 方法利用《
药物经济学评价报告质量评估指南》(简称“PEERs”) 对中国学者已公开发表的他汀类药物经济学 …
药物经济学评价报告质量评估指南》(简称“PEERs”) 对中国学者已公开发表的他汀类药物经济学 …
[PDF][PDF] Quality Assessment of Domestic Statin Economics Research Based on the Guidelines for Quality Assessment of Pharmacoeconomic Evaluation Report (PEERs …
S Yingying, HE Xiaojing, J Lingyan - Herald of Medicine, 2021 - yydbzz.com
Objective To investigate the quality of domestic economic evaluations of statins and to point
out the key points for further improvement and standardization in this field. Methods The …
out the key points for further improvement and standardization in this field. Methods The …
Assessing risk thresholds of initiating statins among Chinese
Y Jiang - PharmacoEconomics & Outcomes News, 2019 - Springer
Initiating statin therapy for primary prevention of atherosclerotic cardiovascular disease
(ASCVD) at the 10% 10-year risk threshold is cost effective for middleaged and elderly …
(ASCVD) at the 10% 10-year risk threshold is cost effective for middleaged and elderly …